{
  "actions": [
    {
      "acted_at": "2016-01-12", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2016-01-12", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2443-114", 
  "bill_type": "s", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "114", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-01-12", 
  "number": "2443", 
  "official_title": "A bill to support the establishment of a Standards Coordinating Body in Regenerative Medicine and Advanced Therapies.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4669-114", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Advancing Standards in Regenerative Medicine Act", 
  "sponsor": {
    "bioguide_id": "B001230", 
    "district": null, 
    "name": "Baldwin, Tammy", 
    "state": "WI", 
    "thomas_id": "01558", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-01-12", 
  "subjects": [
    "Cell biology and embryology", 
    "Drug safety, medical device, and laboratory regulation", 
    "Genetics", 
    "Health", 
    "Medical research", 
    "Organ and tissue donation and transplantation", 
    "Public-private cooperation"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2016-01-12T05:00:00Z", 
    "text": "Advancing Standards in Regenerative Medicine Act\n\nThis bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to facilitate the establishment of a public-private Standards Coordinating Body in Regenerative Medicine and Advanced Therapies. The FDA must work with this body to develop standards to support the development and review of regenerative medicine products."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Advancing Standards in Regenerative Medicine Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to support the establishment of a Standards Coordinating Body in Regenerative Medicine and Advanced Therapies.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Advancing Standards in Regenerative Medicine Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:31:10Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/s/BILLSTATUS-114s2443.xml"
}